1-3 of 3
Konstantinos Syrigos
Close
Sort by
Journal Articles

Rapid Reduction of Anti-Sars-Cov-2 Antibodies in Convalescent Plasma Donors; Results of a Phase 2 Clinical Study

Evangelos Terpos, MDPhD, Marianna Politou, MD, Theodoros N Sergentanis, MD PhD, Andreas Mentis, MD, Vassiliki Pappa, MD, Maria Pagoni, MD, Elisavet Grouzi, MD, Stavroula Labropoulou, PhD, Ioanna Charitaki, Dimitra Moschandreou, MD, Anthi Bouhla, MD, Stylianos Saridakis, MD, Eleni Korompoki, MD, Chara Giatra, MD, Tina Bagratuni, PhD, Angelos Pefanis, MD, Sotirios Papageorgiou, MD PhD, Alexandros Spyridonidis, MD PhD, Anastasia Antoniadou, MD PhD, Anastasia Kotanidou, MD, Konstantinos Syrigos, MD PhD, Konstantinos Stamoulis, MD, George Panayiotakopoulos, MD PhD, Sotirios Tsiodras, MD PhD, Leonidas Alexopoulos, PhD, Meletios A Dimopoulos
Journal: Blood
Blood (2020) 136 (Supplement 1): 1–2.
https://doi.org/10.1182/blood-2020-136940
Published: 2020
Journal Articles

Prospective Assessment of Clinical Risk Factors and Biomarkers of Hypercoagulability for the Identification of Patients with Lung Adenocarcinoma at Risk for Cancer Associated Thrombosis. the Observational Roadmap-CAT Study

Grigorios T. Gerotziafas, MD PhD, Patrick Van Dreden, PhD, Stella Salta, Loula Papageorgiou, Paraskevi Boura, Annette Larsen, Jawed Fareed, PhD, Konstantinos Syrigos, Ismail Elalamy, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2381.
https://doi.org/10.1182/blood.V130.Suppl_1.2381.2381
Published: 2017
Journal Articles

Differential Influence of Lung Cancer Stage, Time from Diagnosis and Chemotherapy on Plasma and Cellular Biomarkers of Hypercoagulability. the Roadmap Study

Ilias Evmorfiadis, Paraskevi Boura, Aurélie Rousseau, Ariadni Charpidou, Giannis Giozos, Patrick Van Dreden, PhD, Konstantinos Syrigos, Anastasia Spanoudaki, Matthieu Grusse, Ismail Elalamy, MD, Grigorios T. Gerotziafas, Dr
Journal: Blood
Blood (2014) 124 (21): 4253.
https://doi.org/10.1182/blood.V124.21.4253.4253
Published: 2014